Misión Salud project

The Board of Directors of the Center for Technological Development and Innovation, E.P.E. (CDTI), in its meeting on December 22, 2023, agreed to grant EBERS MEDICAL TECHNOLOGY S.L. support for the development of the RESEARCH AND DEVELOPMENT Project 'Mission Health Project' named 'REGENERATION OF MARGINAL ORGANS WITH EX VIVO CELLULAR THERAPY IN PROLONGED NORMOTHERMIC PERFUSION FOR ELDERLY PATIENTS WITH CHRONIC AND ONCOLOGICAL DISEASES' (IDI-20230945).

This support is co-financed by the European Union's Recovery and Resilience Mechanism, established by Council Regulation (EU) 2020/2094 of December 14, 2020, which establishes a European Union Recovery Instrument to support recovery following the COVID-19 crisis, and regulated according to Regulation (EU) 2021/241 of the European Parliament and of the Council of February 12, 2021, which establishes the Recovery and Resilience Mechanism, specifically through budget line 28.50.460E.749.14 of the 2021 General State Budgets.

The project is part of the joint action between the Carlos III Health Institute, O.A., M.P. (ISCIII) and the CDTI, framed within the Strategic Project for Economic Recovery and Transformation for Cutting-Edge Health (PERTE de Salud). It will be carried out jointly with the group of researcher Dr. Pedro Baptista from IIS Aragón.